• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观扩散系数在预测胸腺瘤患者病理 T 分期中的诊断价值。

Diagnostic value of apparent diffusion coefficient in predicting pathological T stage in patients with thymic epithelial tumor.

机构信息

Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medical College, National Cheng Kung University, Tainan, Taiwan.

Department of Medical Imaging, National Cheng Kung University Hospital, College of Medical College, National Cheng Kung University, Tainan, Taiwan.

出版信息

Cancer Imaging. 2022 Oct 5;22(1):56. doi: 10.1186/s40644-022-00495-x.

DOI:10.1186/s40644-022-00495-x
PMID:36199129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9533584/
Abstract

PURPOSES

This study aimed to evaluate the diagnostic capacity of apparent diffusion coefficient (ADC) in predicting pathological Masaoka and T stages in patients with thymic epithelial tumors (TETs).

METHODS

Medical records of 62 patients who were diagnosed with TET and underwent diffusion-weighted imaging (DWI) prior to surgery between August 2017 and July 2021 were retrospectively analyzed. ADC values were calculated from DWI images using b values of 0, 400, and 800 s/mm. Pathological stages were determined by histological examination of surgical specimens. Cut-off points of ADC values were calculated via receiver operating characteristic (ROC) analysis.

RESULTS

Patients had a mean age of 56.3 years. Mean ADC values were negatively correlated with pathological Masaoka and T stages. Higher values of the area under the ROC curve suggested that mean ADC values more accurately predicated pathological T stages than pathological Masaoka stages. The optimal cut-off points of mean ADC were 1.62, 1.31, and 1.48 × 10 mm/sec for distinguishing pathological T2-T4 from pathological T1, pathological T4 from pathological T1-T3, and pathological T3-T4 from pathological T2, respectively.

CONCLUSION

ADC seems to more precisely predict pathological T stages, compared to pathological Masaoka stage. The cut-off values of ADC identified may be used to preoperatively predict pathological T stages of TETs.

摘要

目的

本研究旨在评估表观扩散系数(ADC)在预测胸腺瘤(TET)患者病理 Masaoka 和 T 分期中的诊断能力。

方法

回顾性分析了 2017 年 8 月至 2021 年 7 月期间 62 例经手术前弥散加权成像(DWI)诊断为 TET 并接受检查的患者的病历。从 DWI 图像中使用 b 值为 0、400 和 800 s/mm2 计算 ADC 值。通过手术标本的组织学检查确定病理分期。通过受试者工作特征(ROC)分析计算 ADC 值的截断点。

结果

患者的平均年龄为 56.3 岁。平均 ADC 值与病理 Masaoka 和 T 分期呈负相关。ROC 曲线下面积较高表明平均 ADC 值比病理 Masaoka 分期更准确地预测病理 T 分期。用于区分病理 T2-T4 与病理 T1、病理 T4 与病理 T1-T3 以及病理 T3-T4 与病理 T2 的平均 ADC 的最佳截断点分别为 1.62、1.31 和 1.48×10mm/sec。

结论

与病理 Masaoka 分期相比,ADC 似乎更能准确预测病理 T 分期。确定的 ADC 截断值可用于术前预测 TET 的病理 T 分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/9533584/652a60cfb302/40644_2022_495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/9533584/bb90b08d0675/40644_2022_495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/9533584/652a60cfb302/40644_2022_495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/9533584/bb90b08d0675/40644_2022_495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/9533584/652a60cfb302/40644_2022_495_Fig2_HTML.jpg

相似文献

1
Diagnostic value of apparent diffusion coefficient in predicting pathological T stage in patients with thymic epithelial tumor.表观扩散系数在预测胸腺瘤患者病理 T 分期中的诊断价值。
Cancer Imaging. 2022 Oct 5;22(1):56. doi: 10.1186/s40644-022-00495-x.
2
Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging.表观扩散系数图的直方图分析用于评估胸腺上皮肿瘤:与世界卫生组织分类及临床分期的相关性
Br J Radiol. 2018 Apr;91(1084):20170580. doi: 10.1259/bjr.20170580. Epub 2018 Jan 10.
3
Predicting pathological subtypes and stages of thymic epithelial tumors using DWI: value of combining ADC and texture parameters.使用 DWI 预测胸腺瘤的病理亚型和分期:联合 ADC 值和纹理参数的价值。
Eur Radiol. 2019 Oct;29(10):5330-5340. doi: 10.1007/s00330-019-06080-4. Epub 2019 Mar 15.
4
Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.胸腺瘤的扩散加权磁共振成像:表观扩散系数在预测世界卫生组织(WHO)分类和Masaoka-Koga分期系统中的能力及其对无病生存期的预后意义。
Eur Radiol. 2016 Jul;26(7):2126-38. doi: 10.1007/s00330-015-4031-6. Epub 2015 Oct 1.
5
Intravoxel incoherent motion diffusion-weighted MR imaging parameters predict pathological classification in thymic epithelial tumors.体素内不相干运动扩散加权磁共振成像参数可预测胸腺上皮肿瘤的病理分类。
Oncotarget. 2017 Jul 4;8(27):44579-44592. doi: 10.18632/oncotarget.17857.
6
Multiparametric Magnetic Resonance Imaging for Assessing Thymic Epithelial Tumors: Correlation With Pathological Subtypes and Clinical Stages.多参数磁共振成像在胸腺瘤评估中的应用:与病理亚型和临床分期的相关性。
J Magn Reson Imaging. 2022 Nov;56(5):1487-1496. doi: 10.1002/jmri.28198. Epub 2022 Apr 13.
7
Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps.预测直肠癌不同阶段:基于扩散加权图像和表观扩散系数图的纹理分析。
World J Gastroenterol. 2020 May 7;26(17):2082-2096. doi: 10.3748/wjg.v26.i17.2082.
8
Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging.胸腺上皮肿瘤的弥散加权磁共振成像:与世界卫生组织分类和临床分期的相关性。
Radiology. 2014 Oct;273(1):268-75. doi: 10.1148/radiol.14131643. Epub 2014 May 31.
9
Quantitative Histogram Analysis of T2-Weighted and Diffusion-Weighted Magnetic Resonance Images for Prediction of Malignant Thymic Epithelial Tumors.基于 T2 加权像和弥散加权像的定量直方图分析对胸腺癌的预测价值。
J Comput Assist Tomogr. 2021;45(5):795-801. doi: 10.1097/RCT.0000000000001197.
10
Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage.上皮性卵巢癌的扩散加权磁共振成像:表观扩散系数值与组织学分级及手术分期的相关性
Eur J Radiol. 2015 Apr;84(4):590-5. doi: 10.1016/j.ejrad.2015.01.005. Epub 2015 Jan 16.

引用本文的文献

1
Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer.扩散加权磁共振成像衍生的表观扩散系数(ADC)和肿瘤体积作为肌肉浸润性膀胱癌新辅助化疗反应的预测性影像标志物。
BMC Med Imaging. 2025 Jan 2;25(1):3. doi: 10.1186/s12880-024-01547-3.

本文引用的文献

1
The eighth edition TNM stage classification for thymic tumors: What do I need to know?胸腺肿瘤的第八版TNM分期分类:我需要了解什么?
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1524-1529. doi: 10.1016/j.jtcvs.2020.10.131. Epub 2020 Nov 13.
2
Classification and staging of thymoma.胸腺瘤的分类与分期
J Thorac Dis. 2020 Dec;12(12):7607-7612. doi: 10.21037/jtd-2019-thym-01.
3
Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors.细胞外容积分数测量与胸腺癌上皮肿瘤中的淋巴细胞丰度相关。
Cancer Imaging. 2020 Oct 7;20(1):71. doi: 10.1186/s40644-020-00349-4.
4
MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes.胸腺瘤的 MRI 表现:一种联合放射组学列线图预测组织学亚型。
Eur Radiol. 2021 Jan;31(1):447-457. doi: 10.1007/s00330-020-07074-3. Epub 2020 Jul 22.
5
Thymic epithelial tumors: From biology to treatment.胸腺上皮肿瘤:从生物学到治疗。
Cancer Treat Rev. 2020 Jun;86:102014. doi: 10.1016/j.ctrv.2020.102014. Epub 2020 Mar 23.
6
Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response.弥散加权磁共振成像(DW-MRI)作为一种非侵入性的组织细胞标志物,可用于监测癌症治疗反应。
BMC Cancer. 2020 Feb 19;20(1):134. doi: 10.1186/s12885-020-6617-x.
7
Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.美国胸腺瘤、胸腺癌和胸腺神经内分泌肿瘤发病率的趋势。
PLoS One. 2019 Dec 31;14(12):e0227197. doi: 10.1371/journal.pone.0227197. eCollection 2019.
8
Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014.日本胸腺瘤治疗:2012-2014 年医院癌症登记和保险索赔数据分析。
Jpn J Clin Oncol. 2020 Mar 9;50(3):310-317. doi: 10.1093/jjco/hyz167.
9
A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study.胸腺瘤复发预测模型及其对术后管理的意义:中国胸腺瘤研究联盟数据库研究。
J Thorac Oncol. 2020 Mar;15(3):448-456. doi: 10.1016/j.jtho.2019.10.018. Epub 2019 Nov 11.
10
Optimal management of thymic malignancies: current perspectives.胸腺恶性肿瘤的优化管理:当前观点
Cancer Manag Res. 2019 Jul 22;11:6803-6814. doi: 10.2147/CMAR.S171683. eCollection 2019.